Toll like receptors and their therapeutic potential

Cell basis of this disease: Why did the discovery of Toll-like receptors completely change our understanding of how the innate immune system works and what the treatment possibilities are? There are two immune systems in the body. It is an innate immune system and an adaptive immune system. Adaptive immunization or adaptive immunity refers to an antigen specific defense mechanism that takes several days to become defensive and is designed to react with specific antigens to eliminate specific antigens. This is life development of immune development.

The use of biological materials to modify and control immune responses is a rapidly evolving field with the potential to create therapeutic applications for autoimmune diseases. The use of vaccines as multiple antigens, containers for Toll-like receptor ligands, chemokines, cytokines, etc. are being studied as therapeutic options. By mimicking the concept of a pathogen, both microparticles and nanoparticles can present antigen and PAMP to dendritic cells and enhance the antigen-specific response of the immune system. The various parameters of these particles, such as size, geometry, surface and structural properties, and material selection, are important aspects to consider when trying to optimize the innate immune response to the target antigen. By regulating regulatory T cell responses, it is expected that this concept can be used for autoimmune diseases.

Vaccines using dendritic cell derived antigens or combinations of tumor specific peptides and potent adjuvants such as Toll like receptor (TLR) agonists are potent stimulators of the immune response. Vaccination is known to induce an immune response in T cells. Antigenic peptides of tumor cells produced in the proteasome are identified and then presented in the MHC class I process. However, not all cancer cells present peptides during proteasome degradation. It has been observed that several cancer cells, such as melanoma, can be produced by degradation of potassasomes that are not adjacent to major proteins. This problem can be solved by using a more stable peptide